Madrigal Pharmaceuticals Income from Continuous Operations 2010-2024 | MDGL
Madrigal Pharmaceuticals income from continuous operations for the twelve months ending June 30, 2024 was $-0.510B, a 54.78% increase year-over-year.
- Madrigal Pharmaceuticals annual income from continuous operations for 2023 was $-0.374B, a 26.5% increase from 2022.
- Madrigal Pharmaceuticals annual income from continuous operations for 2022 was $-0.295B, a 22.12% increase from 2021.
- Madrigal Pharmaceuticals annual income from continuous operations for 2021 was $-0.242B, a 19.58% increase from 2020.